Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria

Authors Staevska MT

Received 25 August 2016

Accepted for publication 9 October 2016

Published 25 November 2016 Volume 2016:12 Pages 1793—1796

DOI https://doi.org/10.2147/TCRM.S120628

Checked for plagiarism Yes

Editor who approved publication: Professor Garry Walsh

Maria T Staevska

Clinical Center of Allergology, Medical University, Sofia, Bulgaria
 
As a group of allergists who treat both allergic rhinitis and urticaria patients on a daily basis, and involved in clinical research, we read with particular interest the review paper “Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine”,1 published in your journal. Although the group of distinguished authors from the Asia Pacific Region provide an interesting insight into the burden of allergic diseases in this fast developing part of the world, no new data or insights are offered for the treatment of these diseases. Our attention was particularly drawn by Figure 9, which is partly based on data generated in a clinical study performed and published by our group.
The original article article by Wang et al.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]